Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BURLEY MINERALS LTD Major Shareholding Notification 2021

Jul 7, 2021

64583_rns_2021-07-07_e273b663-dbf9-4780-8d4c-b71706b57f55.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Form 603

Corporations Act 2001

Section 671B

Notice of initial substantial holder

To Company Name/Scheme Burley Minerals Limited ACN/ARSN 645 324 992 1. Details of substantial holder (1) Name Clive Jones ACN / ARSN (if applicable) The holder became a substantial 07/07/2021 holder on

2. Details of voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:

Class ofsecurities (4) Numberofsecurities Persons’ votes (5) Voting power(6)
Ordinary 4,935,000 4,935,000 8.09%

3. Details of relevant interests

The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

Holderof relevantinterest Nature of relevantinterest (7) Class andnumberofsecurities
Clive Jones Trust> Power to dispose of or vote the shares
held by the Alyse Investment Trust
pursuant to S608(1) of the
CorporationsAct
4,575,000
Clive Jones Power to dispose of or vote the shares
held by Widerange Corporation Pty Ltd
pursuant to S608(1) of the
CorporationsAct
350,000
Clive Jones A/C> Power to dispose of or vote the shares
held by the FCFC Legends A/C
pursuant to S608(1) of the
CorporationsAct
10,000

4. Details of present registered holders

The persons registered as holders of the securities referred to in paragraph 3 above are as follows:

Holder of relevant
interest
Registered holder of
securities
Person entitled to be registered
asholder(8)
Class and number of
securities
Clive Jones Clive Jones InvestmentTrust> Clive Jones Trust> 4,575,000 ordinary shares
Clive Jones Widerange
Corporation PtyLtd
Widerange Corporation Pty Ltd 350,000 ordinary shares
Clive Jones Clive Jones LegendsA/C> Clive Jones A/C> 10,000 ordinary shares

5. Consideration

The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:

Holder of relevant
interest
Date of acquisition Consideration(9) Consideration(9) Class and number of
securities
Cash Non-cash
Clive Jones Investment Trust> 1 July 2021 N/A Sale of 15.75%
interest in
NovarangePtyLtd
4,500,000 ordinary
shares
Clive Jones InvestmentTrust> 1 July 2021 $0.20 per share N/A 75,000 ordinary
shares
Widerange
Corporation PtyLtd
1 July 2021 $0.20 per share N/A 350,000 ordinary
shares
Clive Jones LegendsA/C> 1 July 2021 $0.20 per share N/A 10,000 ordinary
shares

6. Associates

The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows:

Name andACN/ARSN(ifapplicable) Nature ofassociation
Widerange Corporation Pty Ltd Clive Jones is the sole director and sole secretary of
Widerange Corporation Pty Ltd and has the power to dispose
of or vote the shares held by Widerange Corporation Pty Ltd
pursuant to S608(1) ofthe CorporationsAct

7. Addresses

The addresses of persons named in this form are as follows:

Name Address
Clive Jones 20A Malsbury Street,Bicton,WA, 6157
Widerange Corporation PtyLtd 20A Malsbury Street,Bicton,WA, 6157

Signature

print name Clive Jones Capacity Director sign here date 07 / 07 /2021

DIRECTIONS

  • (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 7 of the form.

  • (2) See the definition of “associate” in section 9 of the Corporations Act 2001.

  • (3) See the definition of “relevant interest” in sections 608 and 671B(7) of the Corporations A.

  • (4) The voting shares of a company constitute one class unless divided into separate classes.

  • (5) The total number of votes attached to all the voting shares in the company or voting interests in the scheme (if any) that the person or an associate has a relevant interest in.

  • (6) The person’s votes divided by the total votes in the body corporate or scheme multiplied by 100.

(7) Include details of:

  • (a) any relevant agreement or other circumstances by which the relevant interest was acquired. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

  • (b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

See the definition of “relevant agreement” in section 9 of the Corporations Act 2001.

  • (8) If the substantial holder is unable to determine the identity of the person (eg. If the relevant interest arises because of an option) write “unknown”.

  • (9) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.